Vilija R Joyce
Overview
Explore the profile of Vilija R Joyce including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
133
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gujral K, Esmaeili A, Leonard S, Shaw J, Joyce V, Panelli D, et al.
Am J Obstet Gynecol
. 2024 Dec;
PMID: 39708938
No abstract available.
2.
Joyce V, Oliva E, Garcia C, Trafton J, Asch S, Wagner T, et al.
Addiction
. 2023 Jul;
118(11):2203-2214.
PMID: 37465971
Aims: To compare healthcare costs and use between United States (US) Veterans Health Administration (VHA) patients with opioid use disorder (OUD) who experienced an opioid overdose (OD cohort) and patients...
3.
Katon J, Shaw J, Joyce V, Schmitt S, Phibbs C
Womens Health Issues
. 2022 Jan;
32(4):411-417.
PMID: 35074265
Introduction: Little is known about access to and use of prenatal care by veterans using U.S. Department of Veterans Affairs (VA) maternity benefits. We compared the timeliness and adequacy of...
4.
Fairley M, Humphreys K, Joyce V, Bounthavong M, Trafton J, Combs A, et al.
JAMA Psychiatry
. 2021 Mar;
78(7):767-777.
PMID: 33787832
Importance: Opioid use disorder (OUD) is a significant cause of morbidity and mortality in the US, yet many individuals with OUD do not receive treatment. Objective: To assess the cost-effectiveness...
5.
Breland J, Joyce V, Frayne S, Phibbs C
Obes Sci Pract
. 2020 Sep;
6(4):434-438.
PMID: 32874677
Objective: The objective was to compare differences in body mass index (BMI) calculated with self-reported versus clinically measured pre-conception data from women veterans in California. Methods: Veterans Health Administration (VHA)...
6.
Desai M, Montez-Rath M, Kapphahn K, Joyce V, Mathur M, Garcia A, et al.
Stat Med
. 2019 May;
38(17):3204-3220.
PMID: 31099433
The treatment of missing data in comparative effectiveness studies with right-censored outcomes and time-varying covariates is challenging because of the multilevel structure of the data. In particular, the performance of...
7.
Joyce V, Sun H, Barnett P, Bansback N, Griffin S, Bayoumi A, et al.
MDM Policy Pract
. 2018 Oct;
2(2):2381468317716440.
PMID: 30288427
The Medical Outcomes Study HIV Health Survey (MOS-HIV) is frequently used in HIV clinical trials; however, scores generated from the MOS-HIV are not suited for cost-effectiveness analyses as they do...
8.
Shaw J, Joyce V, Schmitt S, Frayne S, Shaw K, Danielsen B, et al.
Health Serv Res
. 2018 Sep;
53 Suppl 3:5260-5284.
PMID: 30198185
Objective: To describe variation in payer and outcomes in Veterans' births. Data/setting: Secondary data analyses of deliveries in California, 2000-2012. Study Design: We performed a retrospective, population-based study of all...
9.
Barnett P, Joyce V, Lo J, Gidwani-Marszowski R, Goldhaber-Fiebert J, Desai M, et al.
Value Health
. 2018 Aug;
21(8):921-930.
PMID: 30098669
Objectives: To determine whether implementation of interferon-free treatment for hepatitis C virus (HCV) reached groups less likely to benefit from earlier therapies, including patients with genotype 1 virus or contraindications...
10.
Liu S, Barnett P, Holodniy M, Lo J, Joyce V, Gidwani R, et al.
MDM Policy Pract
. 2018 May;
1.
PMID: 29756049
Background: Chronic hepatitis C viral (HCV) infection affects millions of Americans. Healthcare systems face complex choices between multiple highly efficacious, costly treatments. This study assessed the cost-effectiveness of HCV treatments...